Large Insider Purchases
Institutional-Scale SEC Form 4 Buy Signals
The Signal of $1M+ Conviction
When a corporate executive invests more than $1,000,000 of their own capital into company shares, it represents the highest level of conviction. These seven-figure purchases reflect management's belief in the company's future value.
| Filing Date | Trade Date | Ticker | Company Name | Reporting Person | Relationship | Industry | Type | Price | Qty | Total, $ | Owned After | Change, % |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-29 00:25 | 2025-03-26 | TOI | Oncology Institute, Inc. | BARASCH RICHARD A | Director | Services-Offices & Clinics of Doctors of Medicine | BUY | $1.04 | 1,358,448 | $1,415,095 | 1,775,641 | +325.6% |
| 2025-03-27 18:54 | 2025-03-25 | PPRUX | N/A | O'Connor Caitlin | Other | Other | BUY | $6,000.01 | 210 | $1,262,276 | 210 | +100.0% |
| 2025-03-28 02:42 | 2025-03-25 | AKRO | Akero Therapeutics, Inc. | Graham G. Walmsley | Director | Pharmaceutical Preparations | BUY | $43.94 | 200,000 | $8,787,920 | 1,200,000 | +20.0% |
| 2025-03-28 01:31 | 2025-03-25 | ASAN | Asana Inc. | Moskovitz Dustin A. | Director, Officer, 10% owner - President, CEO, & Chair | Services-Prepackaged Software | BUY | $15.25 | 450,000 | $6,860,250 | 49,698,436 | +0.9% |
| 2025-03-28 01:53 | 2025-03-25 | ZYME | Zymeworks Inc. | EcoR1 Capital, LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $12.61 | 97,349 | $1,227,308 | 17,255,151 | +0.6% |
| 2025-03-28 01:05 | 2025-03-26 | N-A | N/A | Lindberg Brooks | Director | Other | BUY | $12.54 | 450,000 | $5,643,000 | 59,864 | +100.0% |
| 2025-03-28 00:32 | 2025-03-26 | N/A | N/A | Qatar Investment Authority | 10% owner | Other | BUY | $17.32 | 1,298,716 | $22,500,000 | 4,783,636 | +37.3% |
| 2025-03-27 18:34 | 2025-03-25 | N/A | N/A | Golub David | Director, Officer - CEO and Trustee | Other | BUY | $25.10 | 261,781 | $6,570,703 | 261,781 | +100.0% |
| 2025-03-27 23:15 | 2025-03-25 | PBF | PBF Energy Inc. | Control Empresarial de Capitales S.A. de C.V. | 10% owner, Other | Petroleum Refining | BUY | $19.51 | 165,000 | $3,219,216 | 30,514,998 | +0.5% |
| 2025-03-27 21:58 | 2025-03-25 | N/A | N/A | PRUDENTIAL INSURANCE CO OF AMERICA | 10% owner | Other | BUY | $28.53 | 1,393,289 | $39,749,969 | 1,480,681 | +1,594.3% |
| 2025-03-27 00:00 | 2025-03-24 | GSHR | Gesher Acquisition Corp. II | Gesher Acquisition Sponsor II LLC | Director, Officer, 10% owner - See Remarks | Blank Checks | BUY | $10.00 | 403,125 | $4,031,250 | 403,125 | +100.0% |
| 2025-03-27 04:22 | 2025-03-24 | AEVA | Aeva Technologies, Inc. | SYLEBRA CAPITAL LLC | 10% owner | Motor Vehicle Parts & Accessories | BUY | $4.90 | 2,290,022 | $11,229,810 | 12,669,326 | +22.1% |
| 2025-03-26 23:45 | 2025-03-01 | N-A | N/A | Partners Group Finance USD IC Ltd | Other | Other | BUY | $1.99 | 4,022,324 | $8,004,425 | 0 | +100.0% |
| 2025-03-27 00:41 | 2024-12-26 | XCUR | EXICURE, INC. | HiTron Systems Inc. | 10% owner | Pharmaceutical Preparations | BUY | $3.00 | 2,900,000 | $8,700,000 | 3,333,333 | +669.2% |
| 2025-03-25 23:32 | 2025-03-21 | QTI | QT IMAGING HOLDINGS, INC. | Katz Avi S | Director, Officer - Chairman | Electromedical & Electrotherapeutic Apparatus | BUY | $0.58 | 2,788,843 | $1,628,684 | 775,571 | +100.0% |
| 2025-03-26 02:02 | 2025-03-21 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | Ophthalmic Goods | BUY | $17.66 | 136,696 | $2,414,721 | 12,319,691 | +1.1% |
| 2025-03-25 15:00 | 2025-03-21 | WYNN | WYNN RESORTS LTD | FERTITTA TILMAN J | 10% owner | Hotels & Motels | BUY | $83.73 | 16,500 | $1,381,502 | 12,600,000 | +0.1% |
| 2025-03-25 00:00 | 2025-03-24 | ATAI | Atai Beckley N.V. | Apeiron Investment Group Ltd. | 10% owner | Pharmaceutical Preparations | BUY | $1.40 | 1,800,000 | $2,520,000 | 42,369,415 | +4.4% |
| 2025-03-24 23:15 | 2025-03-20 | TAKNX | N/A | Corebridge Financial, Inc. | Other | Other | BUY | $25.00 | 1,600,000 | $40,000,000 | 320,000 | +100.0% |
| 2025-03-24 17:54 | 2025-03-01 | N-A | N/A | Partners Group Finance USD IC Ltd | Other | Other | BUY | $1.61 | 4,033,009 | $6,493,144 | 0 | +100.0% |
| 2025-03-24 23:20 | 2025-03-20 | N/A | N/A | Amwal Investments LLC | 10% owner | Other | BUY | $25.15 | 496,958 | $12,498,491 | 2,491,702 | +24.9% |
| 2025-03-25 00:45 | 2025-03-20 | ZYME | Zymeworks Inc. | EcoR1 Capital, LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $12.92 | 127,198 | $1,643,246 | 17,157,802 | +0.7% |
| 2025-03-24 16:13 | 2025-03-21 | GSAT | Globalstar, Inc. | Monroe James III | Director, 10% owner | Communications Services, NEC | BUY | $22.31 | 50,000 | $1,115,620 | 947,273 | +5.6% |
| 2025-03-25 04:34 | 2025-03-20 | MODD | Modular Medical, Inc. | MANCHESTER MANAGEMENT CO LLC | Director, Officer, 10% owner, Other - Chief Executive Officer | Surgical & Medical Instruments & Apparatus | BUY | $1.92 | 677,082 | $1,299,997 | 422,000 | +100.0% |
| 2025-03-25 01:20 | 2025-03-21 | GDRZF | GOLD RESERVE LTD | Camac Capital, LLC | 10% owner | Gold and Silver Ores | BUY | $8.50 | 433,400 | $3,682,600 | 9,516,253 | +4.8% |
| 2025-03-24 23:12 | 2025-03-21 | SBGI | Sinclair, Inc. | SMITH DAVID D | Director, Officer, 10% owner - Executive Chairman | Television Broadcasting Stations | BUY | $17.00 | 110,566 | $1,879,511 | 1,082,771 | +11.4% |
| 2025-03-22 00:36 | 2025-03-21 | ECAT | BlackRock ESG Capital Allocation Term Trust | BlackRock, Inc. | Other | Other | BUY | $16.20 | 101,600 | $1,645,920 | 1,176,800 | +9.4% |
| 2025-03-21 23:25 | 2025-03-04 | RPT | Rithm Property Trust Inc. | Rithm Capital Corp. | 10% owner | Real Estate Investment Trusts | BUY | $25.00 | 400,000 | $10,000,000 | 400,000 | +100.0% |
| 2025-03-21 23:52 | 2025-03-19 | TBRG | TruBridge, Inc. | L6 Holdings Inc. | 10% owner | Services-Computer Programming Services | BUY | $27.27 | 96,607 | $2,634,579 | 1,925,000 | +5.3% |
| 2025-03-21 01:09 | 2025-03-20 | ECAT | BlackRock ESG Capital Allocation Term Trust | BlackRock, Inc. | Other | Other | BUY | $16.31 | 101,600 | $1,657,096 | 1,075,200 | +10.4% |
| 2025-03-21 01:41 | 2025-03-18 | ASAN | Asana Inc. | Moskovitz Dustin A. | Director, Officer, 10% owner - President, CEO, & Chair | Services-Prepackaged Software | BUY | $14.15 | 675,000 | $9,551,250 | 49,248,436 | +1.4% |
| 2025-03-21 02:51 | 2025-03-18 | STAA | STAAR SURGICAL CO | BROADWOOD PARTNERS, L.P. | 10% owner | Ophthalmic Goods | BUY | $17.77 | 201,844 | $3,586,283 | 12,182,995 | +1.7% |
| 2025-03-21 00:35 | 2025-03-18 | FLWS | 1 800 FLOWERS COM INC | Fund 1 Investments, LLC | 10% owner | Retail-Retail Stores, NEC | BUY | $5.61 | 201,500 | $1,131,221 | 8,035,969 | +2.6% |
| 2025-03-21 02:50 | 2025-03-18 | RNAC | Cartesian Therapeutics, Inc. | SPRINGER TIMOTHY A | Director, 10% owner | Pharmaceutical Preparations | BUY | $15.26 | 89,863 | $1,371,157 | 8,621,325 | +1.1% |
| 2025-03-20 19:54 | 2025-03-18 | SBGI | Sinclair, Inc. | SMITH DAVID D | Director, Officer, 10% owner - Executive Chairman | Television Broadcasting Stations | BUY | $15.80 | 66,229 | $1,046,345 | 967,589 | +7.3% |
| 2025-03-19 23:44 | 2025-02-28 | N-A | N/A | Bain Capital DCB Investments, LP | 10% owner | Other | BUY | $25.58 | 508,208 | $13,000,000 | 3,988,208 | +14.6% |
| 2025-03-20 02:46 | 2025-03-19 | ECAT | BlackRock ESG Capital Allocation Term Trust | BlackRock, Inc. | Other | Other | BUY | $16.21 | 101,600 | $1,646,936 | 973,600 | +11.7% |
| 2025-03-19 23:01 | 2025-03-17 | GOGO | Gogo Inc. | TOWNSEND CHARLES C | Director | Communications Services, NEC | BUY | $6.66 | 200,000 | $1,331,340 | 1,940,688 | +11.5% |
| 2025-03-20 01:32 | 2025-03-17 | ZYME | Zymeworks Inc. | EcoR1 Capital, LLC | Director, 10% owner | Pharmaceutical Preparations | BUY | $12.55 | 228,463 | $2,866,548 | 17,030,604 | +1.4% |
| 2025-03-20 02:40 | 2025-03-14 | OPRX | OptimizeRx Corp | Lang James Paul | Director | Services-Business Services, NEC | BUY | $7.60 | 321,408 | $2,443,761 | 389,452 | +472.4% |
| 2025-03-19 23:01 | 2025-03-17 | PSEC | PROSPECT CAPITAL CORP | Barry John F | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | Other | BUY | $4.30 | 240,000 | $1,033,104 | 82,461,933 | +0.3% |
| 2025-03-20 01:40 | 2025-03-17 | IMCR | Immunocore Holdings plc | BAKER BROS. ADVISORS LP | Director | Biological Products, (No Diagnostic Substances) | BUY | $29.72 | 807,338 | $23,993,197 | 2,144,060 | +60.4% |
| 2025-03-19 01:53 | 2025-03-18 | ECAT | BlackRock ESG Capital Allocation Term Trust | BlackRock, Inc. | Other | Other | BUY | $16.12 | 101,600 | $1,637,792 | 872,000 | +13.2% |
| 2025-03-19 02:20 | 2025-03-17 | FORFX | N/A | Fisk Darren | Director | Other | BUY | $9.68 | 154,959 | $1,500,000 | 312,374 | +98.4% |
| 2025-03-18 23:38 | 2025-03-14 | WEST | Westrock Coffee Co | Kruczek Robert Patrick | Director | Beverages | BUY | $6.82 | 150,000 | $1,023,570 | 175,740 | +582.8% |
| 2025-03-18 23:31 | 2025-03-14 | LVS | LAS VEGAS SANDS CORP | Pant Muktesh | Director | Hotels & Motels | BUY | $43.51 | 23,000 | $1,000,730 | 23,000 | +100.0% |
| 2025-03-18 23:05 | 2025-03-14 | PSEC | PROSPECT CAPITAL CORP | Barry John F | Director, Officer, 10% owner - CHIEF EXECUTIVE OFFICER | Other | BUY | $4.28 | 240,000 | $1,026,600 | 82,221,933 | +0.3% |
| 2025-03-18 01:58 | 2025-03-17 | ECAT | BlackRock ESG Capital Allocation Term Trust | BlackRock, Inc. | Other | Other | BUY | $16.18 | 101,600 | $1,643,888 | 770,400 | +15.2% |
| 2025-03-18 01:03 | 2025-03-13 | BTMD | biote Corp. | Guines LLC | 10% owner | Medicinal Chemicals & Botanical Products | BUY | $3.25 | 856,609 | $2,784,408 | 3,927,547 | +27.9% |
| 2025-03-18 04:05 | 2025-03-13 | MLYS | Mineralys Therapeutics, Inc. | Samsara BioCapital GP, LLC | 10% owner | Pharmaceutical Preparations | BUY | $13.50 | 600,000 | $8,100,000 | 5,674,916 | +11.8% |
Institutional Conviction in Form 4
Tracking these institutional-scale purchases allows you to follow the "smart money" when their conviction is highest. When an executive or a 10% beneficial owner commits a seven-figure sum to an open-market transaction, it bypasses the routine noise of stock-based compensation. These trades are often a precursor to major corporate developments or a signal that management views the current market valuation as significantly disconnected from the company’s internal growth trajectory. By monitoring these high-value entries, investors can align their portfolios with the capital of those who possess the most intimate understanding of a business's long-term health and potential.
Filtering the Market Noise
Our platform is designed to eliminate the noise and focus strictly on high-impact accumulation from directors and CEOs betting big on their company’s future. The SEC EDGAR database is frequently flooded with thousands of automated Form 4 filings, many of which involve small, technical, or pre-scheduled trades that offer little predictive value for the average investor. By applying a strict $1,000,000 minimum threshold, we isolate the transactions where insiders are taking substantial personal financial risk. This high-conviction filter serves as a powerful transparency tool, identifying the exact moments when corporate leadership moves away from passive ownership toward aggressive capital deployment.
UNDERSTANDING THE DATA
FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.
TRADE DATE: The actual day the insider executed the purchase or sale in the market.
INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.
OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.
CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.
TRADE TYPES DEFINITIONS
BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.
SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.
OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.